REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Ovarian Cancer · Advanced Ovarian Carcinoma · Fallopian Tube Carcinoma · Primary Peritoneal Cancer · PARP Inhibitor · Fatigue Related to Cancer Treatment · Fatigue in Cancer Survivors

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Colorado Cancer Center-Anschutz, Aurora, Colorado, United States

    Contact: Study coordinator (Evamaria Bravo, MS) · evamaria.kentbravo@cuanschutz.edu · 303-724-0131
    Contact: Principal Investigator (Carolyn Lefkowits, MD, MPH, MS)
  • University of Colorado Boulder, Boulder, Colorado, United States

    Contact: Study coordinator (Madeline Nealis, MPH) · revitalize@colorado.edu · 720-515-9461
    Contact: Study coordinator (Sarah Genung, BA MSc) · revitalize@colorado.edu · 720-515-9461
    Contact: Principal Investigator (Joanna J Arch, PhD)
  • Massachusetts General Hospital-Cancer Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Richard Penson, MBBS) · rpenson@mgb.org · 617-724-4800
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Page Widick, MD) · pwidick@bidmc.harvard.edu · 617-667-2100
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Alexi Wright, MD, MPH) · Alexi_Wright@dfci.harvard.edu · 617-632-2334
    Contact: Principal Investigator (Alexi Wright, MD, MPH)
  • Duke Cancer Center, Durham, North Carolina, United States

    Contact: Study coordinator (Amelia Scott) · amelia.lorenzo@duke.edu · 919-613-4584
    Contact: Principal Investigator (Laura Havrilesky, MD, MHSc)
מובילי המחקר
  • Alexi A Wright, MD, MPH

    Principal Investigator

    Dana-Farber Cancer Institute

  • Joanna J Arch, PhD

    Principal Investigator

    University of Colorado, Boulder